Abstract
Objectives
Our objective was to evaluate the efficacy of pulmonary metastasectomy for postoperative colorectal cancer with hepatic metastasis, and to investigate the role of clinicopathological factors as predictors of outcome.
Methods
Consecutive patients undergoing pulmonary metastasectomy for colorectal cancer with (group PH, n = 27) or without (group P, n = 46) a history of hepatic metastasis were included in the study. Clinicopathological variables, including sex, age, site, carcinoembryonic antigen in the primary tumor, disease-free interval, prior hepatic resection, timing of pulmonary metastases, preoperative chemotherapy, type of pulmonary resection, and number, size, and location of pulmonary metastases were retrospectively collected and investigated for prognostic significance.
Results
Five-year survival rates were 59.5 and 70.0 % for patients with and without a history of hepatic metastasis, respectively; these values did not differ significantly. Among all investigated prognostic variables, sex and number of pulmonary metastases (1 vs. >1) were the most important factors affecting the outcome after colorectal and pulmonary resection. There was no significant difference in overall survival whether it was calculated from the time of resection of the primary colorectal cancer or of pulmonary metastases.
Conclusions
Pulmonary resection is not contraindicated in clinical practice. Significant factors indicating a good prognosis were female sex and the number of pulmonary metastases. Special attention should be paid to comparison of survival among studies.
Similar content being viewed by others
References
Fusai G. Davidson BR: management of colorectal liver metastases. Colorectal Dis. 2003;5:2–23.
Miller G, Biernacki P, Kemeny NE, Gonen M, Downey R, Jarnagin WR, et al. Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. J Am Coll Surg. 2007;205:231–8.
Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer. Ann Surg. 1999;230:309–21.
Robert JH, Ambrogi V, Mermillod B, Dahabreh D, Goldstraw P. Factors influencing long-term survival after lung metastasectomy. Ann Thorac Surg. 1997;63:777–84.
Pihl E, Hughes ES, McDermott FT, Johnson WR, Katrivessis H. Lung recurrence after curative surgery for colorectal cancer. Dis Colon Rectum. 1987;30:417–9.
Goya T, Miyazawa N, Kondo H, Tsuchiya R, Naruke T, Suemasu K. Surgical resection of pulmonary metastases from colorectal cancer: 10-year follow-up. Cancer. 1989;64:1418–21.
Mansel JK, Zinsmeister AR, Pairolero PC, Jett JR. Pulmonary resection of metastatic colorectal adenocarcinoma. A 10 years experience. Chest. 1986;89:109–12.
Riquet M, Foucault C, Cazes A, Mitry E, Dujon A, Le Pimpec Barthes F, et al. Pulmonary resection for metastases of colorectal adenocarcinoma. Ann Thorac Surg. 2010;89:375–80.
Watanabe K, Nagai K, Kobayashi A, Sugito M, Saito N. Factors influencing survival after complete resection of pulmonary metastases from colorectal cancer. Br J Surg. 2009;96:1058–65.
(The back-of-the-book spreadsheets). In: The Japanese Society for cancer of the colon and rectum, editor. The Guidelines for the Treatment of Colorectal Cancer. Year 2010 ed. Tokyo: Kanehara & Co., Ltd.; 2010. p. 60–1.
Sclafani F, Incarbone M, Rimassa L, Personeni N, Giordano L, Alloisio M, et al. The role of hepatic emtastases and pulmonary tumor burden in predicting survival after complete pulmonary resection for colorectal cancer. J Thorac Cardiovasc Surg. 2013;145:97–103.
Sakamoto Y, Sakaguchi Y, Oki E, Minami K, Toh Y, Okamura T. Surgical outcomes after resection of both hepatic and pulmonary metastases from colorectal cancer. Wolrd J Surg. 2012;36:2708–13.
Thomhord NR, Wooler LB, Clagett OT. The surgical treatment of metastatic tumors in the lungs. J Thorac Cardiovasc Surg. 1965;49:357–63.
Rougier P, Milan C, Lazorthes F, Fourtanier G, Partensky C, Baumel H, et al. Prospective study of prognostic factors in patients with unresected metastases from colorectal cancer. Br J Surg. 1995;82:1397–400.
Miller G, Biernacki P, Kemeny NE, Gonen M, Downey R, Jarnagin WR, et al. Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. J Am Coll Surg. 2007;205:231–8.
Kobayashi K, Kawamura M, Ishihara T. Surgical treatment for both pulmonary and hepatic metastases from colorectal cancer. J Thorac Cardiovasc Surg. 1999;118:1090–6.
Nagakura S, Shirai Y, Yamato Y, Yokoyama N, Suda T, Hatakeyama K. Simultaneous detection of colorectal carcinoma liver and lung metastases does not warrant resection. J Am Coll Surg. 2001;193:153–60.
Mineo TC, Ambrogi V, Tonini G, Bollero P, Roselli M, Mineo D, et al. Longterm results after resection of simultaneous and sequential lung and liver metastases from colorectal carcinoma. J Am Coll Surg. 2003;197:386–91.
Schüle S, Dittmar Y, Knösel T, Krieg P, Albrecht R, Settmacher U, et al. Long-term results and prognostic factors after resection of hepatic and pulmonary metastases of colorectal cancer. Int J Colorectal Dis. 2013;28:537–45.
Neeff H, Hörth W, Makowiec F, Fischer E, Imdahl A, Hopt UT, et al. Outcome after resection of hepatic and pulmonary metastases of colorectal cancer. J Gastrointest Surg. 2009;13:1813–20.
Headrick JR, Miller DL, Nagorney DM, Allen MS, Deschamps C, Trastek VF, et al. Surgical treatment of hepatic and pulmonary metastases from colon cancer. Ann Thorac Surg. 2001;71:975–9.
Brouquet A, Vauthey JN, Contreras CM, Walsh GL, Vaporciyan AA, Swisher SG, et al. Improved survival after resection of liver and lung colorectal metastases compared with liver-only metastases: a study of 112 patients with limited lung metastatic disease. J Am Coll Surg. 2011;213:62–9.
Gonzalez M, Robert JH, Halkic N, Mentha G, Roth A, Perneger T, et al. Survival after lung metastasectomy in colorectal cancer patients with previously resected liver metastases. World J Surg. 2012;36:386–91.
Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13:8–10.
Folkman T. Tumor angiogenesis. Adv Cancer Res. 1985;43:175–203.
Kamiyoshihara M, Hirai T, Kawashima O, Morishita Y. Resection of pulmonary metastases in six patients with disease-free interval greater than 10 years. Ann Thorac Surg. 1998;66:231–3.
Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350:2335–42.
Saltz LB, Clarke S, Díaz-Rubio E, Scheithauer W, Figer A, Wong R, et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol. 2008;26:2013–9.
Acknowledgments
We thank Mie Makiguchi, nurse in the General Thoracic Surgery Outpatient Department; Misato Ichida, scientific secretary of General Thoracic Surgery; General Thoracic Surgery nursing staffs; and all staff members involved in this research protocol.
Conflict of interest
The authors declare that we have received no financial support and have no relationships that may pose a conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is based on the Japanese paper: “Kamiyoshihara M, et al. Lung metastasectomy for postoperative colorectal cancer in patients with a history of hepatic metastasis. Kyobu Geka. 2013;66: 291–7. Japanese.”
Rights and permissions
About this article
Cite this article
Kamiyoshihara, M., Igai, H., Kawatani, N. et al. Lung metastasectomy for postoperative colorectal cancer in patients with a history of hepatic metastasis. Gen Thorac Cardiovasc Surg 62, 314–320 (2014). https://doi.org/10.1007/s11748-014-0376-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-014-0376-z